NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1053349027 M.D.
Verify on CMS → Surekha Perlman, M.D.
Endocrinology, Diabetes & Metabolism Physician in Plano, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 203 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
41%
generic claims · 53% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$653.28
16 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Surekha Perlman, M.D. filed 1,072 Medicare Part D claims in 2023 as an Endocrinology, Diabetes & Metabolism Physician in Plano, Texas, prescribing 41% generic.
- 1K
- Part D claims, 2023
- 41%
- generic prescribing
- $653.28
- industry payments (Sunshine Act)
- ≥76th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1053349027 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1053349027
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- RX-MID 1,072
- BOOK-LIGHT 520 in Texas
- PHOTO-ENUM Arthur Rubenstein · 2006
Surekha Perlman, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,072 ≥ 76th percentile 76% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
◑
Board-eligible specialty (heuristic, not verified)
Surekha Perlman, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Surekha Perlman, M.D.?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
1,072 59% vs specialty avg
Specialty distribution in Texas
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Texas providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1053349027 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 06/29/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Surekha Perlman, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$653
Largest payer
Medtronic, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Surekha Perlman, M.D.. To verify Surekha Perlman, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Surekha Perlman, M.D. - brand share 53.0%
Endocrinology, Diabetes & Metabolism Physician average
53% brand-name claims vs 41% generic, on 1,072 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,072
Total Claims
$520K
Total Drug Cost
203
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,648
- Total Day Supply
- 78,231
- Brand vs Generic
- 53% brand / 41% generic
- Brand Drug Cost
- $499K
- Generic Drug Cost
- $14K
- Antibiotic Claims
- 20
Patient Demographics
- Average Patient Age
- 73.0 years
- Avg HCC Risk Score
- 1.39
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 15, 65-74: 108, 75-84: 67, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Surekha Perlman, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Synthroid
Synthroid
151 claims
- Levothyroxine Sodium
Levothyroxine Sodium
147 claims
- Ozempic
Ozempic
81 claims
- Metformin Hcl
Metformin Hcl
77 claims
- Ibandronate Sodium
Ibandronate Sodium
66 claims
- Jardiance 44
Jardiance
44 claims
- Testosterone Cypio… 28
Testosterone Cypionate
28 claims
- Metformin Hcl Er 19
Metformin Hcl Er
19 claims
| Drug | Claims |
|---|---|
| Synthroid Levothyroxine Sodium | 151 |
| Levothyroxine Sodium | 147 |
| Ozempic Semaglutide | 81 |
| Metformin Hcl | 77 |
| Ibandronate Sodium | 66 |
| Jardiance Empagliflozin | 44 |
| Testosterone Cypionate | 28 |
| Metformin Hcl Er Metformin Hcl | 19 |
| Humalog Kwikpen U-100 Insulin Lispro | 16 |
| Hydrocortisone | 16 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in TX →
All providers in Texas →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Surekha Perlman, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Surekha Perlman, M.D.'s 1,072 claims are below the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Perlman, both outside Texas so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Perlman.
One of 520 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Texas, 5 are shown here.
Dr. Nicola Abate
MD
Baytown, TX
Dr. Jessica Abramowitz
MD
Dallas, TX
Dr. Layla Abushamat
M.D., M.P.H.
Houston, TX
Dr. Luis Acosta
MD
Houston, TX
Dr. Stefanie Addington
M.D.
Frisco, TX
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Surekha Perlman, M.D.'s specialty? ▼
Surekha Perlman, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Plano, Texas. Credentials: M.D..
How much does Surekha Perlman, M.D. prescribe under Medicare Part D? ▼
In 2023, Surekha Perlman, M.D. wrote 1,072 Medicare Part D claims totaling $520K in drug costs for 203 beneficiaries.
Where is Surekha Perlman, M.D. located? ▼
Surekha Perlman, M.D. is located at 6124 W PARKER RD, Plano, TX, 75093. Phone: (972) 981-7812.
What is Surekha Perlman, M.D.'s NPI number? ▼
Surekha Perlman, M.D.'s National Provider Identifier (NPI) is 1053349027, issued on 06/29/2006.
Does Surekha Perlman, M.D. prescribe more brand-name or generic drugs? ▼
Surekha Perlman, M.D.'s prescribing is 53% brand-name and 41% generic drugs by claim count, with $499K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Surekha Perlman, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Surekha Perlman, M.D.'s most frequently prescribed drugs include Synthroid, Levothyroxine Sodium, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Surekha Perlman, M.D. accept Medicare? ▼
Surekha Perlman, M.D. appears in CMS Medicare data with 1,072 Part D claims and 203 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Surekha Perlman, M.D.'s credentials? ▼
Surekha Perlman, M.D.'s NPI is 1053349027 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.